True, unbiased discovery in large-scale clinical research is now possible from plasma. Explore every angle of the plasma proteome at unprecedented depth and identify the deepest biological insights for your biomarker discovery.
• Unbiased analysis with unprecedented depth of up to 3,000 of the most relevant proteins
• Unparalleled specificity and quantitative precision
• High-throughput and massively scalable
Harnessing the information present in the plasma proteome requires robust large-scale analytical techniques. Our latest white paper gives you a better understanding of two leading [...]
The brochure provides an overview of the key features and benefits of our next-generation TrueDiscovery™ platform. In addition, it elaborates on our deep and reproducible proteom [...]
Our new White Paper explains how advances in mass spectrometry can now unlock the potential of the plasma proteome, uncovering actionable insights that are essential for biomarker [...]
Our new White Paper explains why oncology drug development fails and how Biognosys’ proteomics platforms and applications can support your oncology research.
We describe a first-of-its-kind study using multi-omics biomarker approaches to demonstrate pharmacodynamic effects and immune modulation in pancreatic cancer. Biognosys’ proprie [...]
The case study elaborates on the results of our pan-cancer proteomics study. We analyzed 180 plasma samples from lung, breast, colorectal, pancreatic, and prostate cancer using our [...]
Tognetti et al. Journal of Proteome Research. The plasma proteome has the potential to enable a holistic analysis of the health state of an individual. Ho [...]
Plasma proteomics is increasingly recognized as a fundamental approach to accelerate biomarker discovery and drug development, taking precision medicine to the next level.
Watch our latest webinars "3D proteome snapshots enable high-resolution functional proteomics screens" and "Immunotherapy meets proteomics: A winning combination for clinical trial [...]
This comprehensive brochure provides an overview of our services offering. Download Brochure
With the 3D Protein Explorer you can visualize the proteomic signature identified with our next-generation Plasma Biomarker Discovery solution in our latest pan-cancer clinical stu [...]
Yuehan Feng, our Director, Scientific Alliances, will walk through the Biognosys offering and processes to deliver you deep proteomics insights. Followed by Jakob Vowinckel, Head o [...]
E-Poster MP014 presented at ASMS 2021 Presenter: Marco Tognetti Session: Biomarkers: Quantitative Analysis Date: Monday, November 1
E-Poster number 90 presented at SITC 2021 Presenter: Kristina Beeler